Predicting decline in left ventricular function after new-onset left bundle branch block
Dylan Goings1, Patricia Carey1, Tristan Meier2
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Insights
Artificial intelligence-derived ECG markers predict left ventricular ejection fraction decline in patients with left bundle branch block. This aids early detection and intervention for heart dysfunction.
Area of Science:
- Cardiology
- Artificial Intelligence in Medicine
- Medical Diagnostics
Background:
- Left bundle branch block (LBBB) is linked to increased risk of left ventricular systolic dysfunction.
- Early identification of high-risk patients with LBBB is crucial for timely management.
Purpose of the Study:
- To identify predictors of significant left ventricular ejection fraction (LVEF) decline in LBBB patients.
- Utilize clinical, echocardiographic, and electrocardiographic (ECG) data for prediction.
Main Methods:
- Retrospective analysis of 769 patients with new LBBB and preserved LVEF (≥50%).
- Cox proportional hazards regression to identify predictors of ≥20% LVEF decline.
- Construction of a risk prediction model.
Main Results:
- 31.5% of patients experienced ≥20% LVEF decline over a median of 4.9 years.
- AI-derived ECG scores for LV systolic and diastolic dysfunction independently predicted LVEF decline.
- The predictive model showed modest discriminative ability (C-index 0.615-0.70).
Conclusions:
- AI-derived ECG markers for LV systolic and diastolic dysfunction predict future LVEF decline in new-onset LBBB.
- Echocardiographic parameters can further enhance risk stratification.
- This framework supports monitoring and early intervention in LBBB patients.
Background:
Left bundle branch block (LBBB) has been associated with an increased risk of incident left ventricular systolic dysfunction. Identifying high-risk patients early is challenging but important for timely management.
Objective:
This study aimed to identify predictors of significant left ventricular ejection fraction (LVEF) decline in patients with LBBB using clinical, echocardiographic, and electrocardiographic (ECG) data.
Methods:
A retrospective cohort of 769 patients with newly diagnosed LBBB and preserved LVEF (≥50%) was analyzed. Univariable and multivariable Cox proportional hazards regression analyses were used to identify predictors of ≥20% LVEF decline on follow-up echocardiography as the primary outcome. A risk prediction model was constructed using pooled estimates.
Results:
Over a median follow-up of 4.9 years (interquartile range 2.3-8.4), 242 patients (31.5%) experienced an LVEF decline of ≥20%. In multivariable Cox regression, 2 artificial intelligence-derived ECG scores previously developed to detect LV systolic and diastolic dysfunction were independently associated with LVEF decline (hazard ratio 1.01, per 1% probability increase for low LVEF; P = .005; hazard ratio 1.25, per predicted diastolic dysfunction grade, P = .005, respectively). The final model demonstrated modest discriminative ability with a C-index of 0.615, improving to 0.65 after adjusting for baseline LVEF and further to 0.70 in a landmark analysis of 1-year follow-up.
Conclusion:
Artificial intelligence-derived ECG markers of LV systolic and diastolic dysfunction independently predicted future LVEF decline in patients with new-onset LBBB. Echocardiographic parameters may also enhance risk stratification. This predictive framework could be used to support monitoring and early intervention strategies in patients with LBBB.
More Related Videos
06:34Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
Related Concept Videos
Mitral Stenosis I: Introduction
Heart Failure Drugs: β-Blockers
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
